Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
Jonathan Pan, Sushil Ghimire, S. Onder Alpdogan, Andrew Chapman, Matthew Carabasi, Martina DiMeglio, Jerald Gong, Ubaldo Martinez-Outschoorn, Lewis Rose, Michael Ramirez, John L. Wagner, Mark Weiss, Neal Flomenberg, Barbara Pro, Pierluigi Porcu, Joanne Filicko-OHara, Sameh Gaballa*
Dive into the research topics of 'Phase I/II study of bendamustine in combination with ofatumumab, carboplatin, etoposide (BOCE) for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma'. Together they form a unique fingerprint.